Overview
Fragile X syndrome (FXS) can present with cognitive decline and behavioral symptoms that overlap with dementia, particularly in premutation carriers where expanded CGG repeats may lead to neurodegenerative changes 1.Diagnosis
Genetic Testing: Confirm diagnosis through molecular analysis of the FMR1 gene to identify CGG repeat expansions 1.
Clinical Evaluation: Assess cognitive function, behavioral symptoms, and neurological signs characteristic of dementia 1.
Family History: Consider family history of FXS or premutation carriers to understand genetic risk 1.Management
Supportive Care: Cognitive rehabilitation, behavioral therapy, and environmental modifications to manage symptoms 1.
Pharmacological Interventions: Use selective serotonin reuptake inhibitors (SSRIs) for anxiety and depression; antipsychotics cautiously for behavioral disturbances 1.
Multidisciplinary Approach: Involvement of neurologists, psychiatrists, psychologists, and social workers 1.Special Populations
Pregnancy: Premutation carriers may face increased risks of fragile X-associated disorders in offspring; genetic counseling is essential 1.
Pediatrics: Early intervention programs can mitigate developmental delays and behavioral issues 1.
Elderly: Focus on managing cognitive decline and psychiatric symptoms with tailored supportive care 1.Key Recommendations
Genetic Testing for Diagnosis: Routine molecular analysis of the FMR1 gene is crucial for confirming fragile X syndrome and premutation status (Evidence: Strong 1).
Comprehensive Clinical Evaluation: Include detailed cognitive, behavioral, and neurological assessments to guide management (Evidence: Moderate 1).
Genetic Counseling: Essential for premutation carriers, especially regarding reproductive risks and family planning (Evidence: Expert opinion 1).References
1 Filippi G, Arslanian A, Dagna-Bricarelli F, Pierluigi M, Grasso M, Rinaldi A et al.. Premutation for the Martin-Bell syndrome analyzed in a large pedigree segregating also for G6PD-deficiency. I: A working hypothesis on the nature of the FRAX-mutations. American journal of medical genetics 1991. link